CAS RN: 90779-69-4

Atosiban

Product Availability

Choose a grade to view its available package options.

6 package records4 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250106 100mg In stock Shanghai Inquiry
Batchno.20251204 10mg In stock Shanghai Inquiry
Batchno.20250612 1mg In stock Shanghai Inquiry
Batchno.20260503 250mg Out of stock Inquiry
Batchno.20250820 50mg Out of stock Inquiry
Batchno.20260120 5mg In stock Shanghai Inquiry
  • Product code: starshine_CAS90779-69-4
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

90779-69-4 / (2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide

Standard CAS: 90779-69-4 Multi CAS: Yes

Basic Information

CAS
90779-69-4
Multi CAS
Yes
Molecular Formula
C43H67N11O12S2
Molecular Weight
994.200000
Exact Mass
993.441209
InChI
InChI=1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63)/t23-,24+,27-,28+,29-,30-,31-,35-,36?/m0/s1
InChIKey
VWXRQYYUEIYXCZ-AVTFEHRISA-N

Computed Properties

Structural Parameters

Heavy atom count
68
Aromatic heavy atom count
6
Fraction Csp3
0.63
Rotatable bonds
18
H-bond acceptors
15
H-bond donors
11
Molar refractivity
252.61
TPSA
365.67

LogP / Solubility

WLOGP
-3.04
MLOGP
-2.58
XLogP3
-1.9
Consensus LogP
-2.51
Log S (ESOL)
-2.96
Class (ESOL)
Moderately soluble
Log S (Ali)
-5.51
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.76
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-10.95

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Get In Touch

Contact Us